Scarica l'app Stockscreener
133.57
0.01%
-0.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Abbott Laboratories Borsa (ABT) Ultime notizie
Test Strip Market Is Booming So Rapidly 2025-2032 -Abbott - openPR.com
Abbott Announces FDA Approval Of Tendyne Transcatheter Mitral Valve Replacement System - insights.citeline.com
Abbott Laboratories Stock: Is ABT Outperforming the Health Care Sector? - MSN
Abbott Laboratories Stock: Is ABT Outperforming The Health Care Sector? - Barchart.com
Goldman Sachs Adjusts Price Target on Abbott Laboratories to $153 From $147, Maintains Buy Rating - marketscreener.com
There's Been No Shortage Of Growth Recently For Abbott Laboratories' (NYSE:ABT) Returns On Capital - Yahoo
Abbott Tendyne TMVR secures FDA clearance - BioWorld MedTech
Cardiac Marker Analyzer Market Is Booming WorldwideAbbott, Roche Diagnostics - openPR.com
Abbott Labs (ABT) Stock Ticks Lower: Gauging the Pulse and Future Price Points - Daily Chhattisgarh News
Abbott Benefits From Libre & Biosimilars Amid FX, Cost Headwinds - TradingView
Cancer Cell Market Projected to Witness Massive GrowthAbbott Laboratories, Novartis - openPR.com
Abbott (ABT) Rises Higher Than Market: Key Facts - Yahoo Finance
Syphilis Market Growth Projections 2023-2032: DelveInsight - openPR.com
MotoAmerica Adopts Ground-Breaking Global Standard for Concussion Safety with Abbott's i-STAT TBI Blood Test - Sports Illustrated
Abbott reports positive dual-chamber pacemaker results - MassDevice
Drug Device Combination Products Market Analysis Report 2025-2030: Discover the Latest Advances and Opportunities - GlobeNewswire Inc.
An Abbott competitor drops out — plus, a special circumstance for Nvidia earnings - CNBC
Abbott Laboratories (NYSE:ABT) Gains FDA Nod For Tendyne Mitral Valve System - simplywall.st
Abbott (ABT) Gains Marginal Benefit from Boston Scientific's Str - GuruFocus
Cancer Diagnostics Market Is Booming WorldwideRoche, Abbott Laboratories - openPR.com
Abbott Stock Gains Following FDA Approval of the Tendyne System - Yahoo
The Zacks Analyst Blog Highlights Coca-Cola, Abbott Laboratories and AT&T - Yahoo Finance
Cardiac Implants Market Is Booming Worldwide | Abbott - openPR.com
Abbott Gains FDA Approval for Tendyne™, Strengthening Its Minimally Invasive Heart Portfolio - Yahoo Finance
Abbott Stakes Claim in TMVR Market with New FDA Approval - Medical Device and Diagnostic industry
Abbott Labs (ABT) Receives FDA Approval for Tendyne Heart Valve System - GuruFocus
Top Stock Reports for Coca-Cola, Abbott & AT&T - Nasdaq
Abbott Laboratories’ SWOT analysis: diversified portfolio bolsters stock amid challenges - Investing.com
FDA approves self-expanding Tendyne TMVR device from Abbott - Cardiovascular Business
Abbott wins approval for open-heart surgery-free valve replacement - Crain's Chicago Business
Biochips Market Poised Boom | Abbott Laboratories, Agilent Technologies, Inc., PerkinElmer, Inc - openPR.com
FDA approves Abbott mitral valve replacement device that doesn't require open-heart surgery - MassDevice
Abbott gets FDA nod for Tendyne valve for mitral valve disease - Seeking Alpha
Abbott Says Tendyne Transcatheter Mitral Valve Replacement System Receives FDA Approval - marketscreener.com
Abbott’s Tendyne valve gets FDA nod for mitral replacement By Investing.com - Investing.com Canada
Abbott (ABT) Receives FDA Approval for Tendyne Heart Valve System | ABT Stock News - GuruFocus
Abbott’s Tendyne valve gets FDA nod for mitral replacement - Investing.com
Oman Dietary Supplements Market Forecast Report to 2030, with Profiles of Nature's Way, Amway, Pfizer Gulf, Abbott Laboratories, Herbalife Nutrition, Nestle & Oman Pharmaceutical Products - GlobeNewswire
A Look At The Intrinsic Value Of Abbott Laboratories (NYSE:ABT) - Yahoo Finance
Abbott Laboratories: Why Wall Street's Skepticism Misses The Real Story - Seeking Alpha
If You Invested $10K In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now? - Yahoo Finance
Abbott Laboratories (ABT) Benefitted From Better Execution - MSN
STHS unveils groundbreaking lab upgrade from Abbott at St. Tammany Parish Hospital - an17.com
Abbott Laboratories (NYSE:ABT) Collaborates On Advanced Diabetes Management With Glucose-Ketone Sensor Integration - simplywall.st
Abbott Laboratories (ABT) was up 16% in Q1 - Insider Monkey
Was Jim Cramer Right About Abbott Laboratories (ABT)? - MSN
Blood Glucose Monitoring (BGM) Devices Market Report 2025: Hospitals Lead in Blood Glucose Monitoring Device Usage, Home Care Grows Fastest - GlobeNewswire Inc.
From Acquisition to Advantage: Abbott's Growth in Heart Care - Yahoo Finance
Abbott vs. Medtronic: Which Dividend-Paying MedTech Stock is Better? - Yahoo Finance
Researchers question reliability of Abbott’s rapid malaria tests - Science | AAAS
Senseonics Holdings, Inc. Secures $57.5 Million in Public Offering and $20.3 Million from Private Placement with Abbott Laboratories - Nasdaq
Senseonics Secures Massive $77.8M Funding Boost as Abbott Backs Next-Gen Diabetes Monitor Launch - Stock Titan
The Growth Of Medical Devices Needs To Continue In Order To Invest In Abbott (NYSE:ABT) - Seeking Alpha
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Do Abbott Laboratories' (NYSE:ABT) Earnings Warrant Your Attention? - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Alcon (ALC) - The Globe and Mail
Solid Results Boosted Abbott Laboratories’ (ABT) Performance in Q1 - Insider Monkey
1.04%
0.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):